Do GLP-1 Drugs Affect Cancer Risk? New Study Says Probably Not
A review of 48 clinical trials on GLP-1 safety suggests the popular meds probably have little to no effect on cancer risk.
Health News is provided as a service to Diabetes Resource Centre site users by HealthDay. Diabetes Resource Centre nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.